Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
imILT in Advanced Pancreatic Carcinoma
NCT03187587Terminated
- Sponsor
- Clinical Laserthermia Systems
- Start
- May 2017
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Open-label trial in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by Clinical Laserthermia Systems. Primary endpoint: Treatment effect by radiology at 12 months. Started May 2017; status: terminated.
02
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03187587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187587.